Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age

Journal of Pediatrics

Volumn 130, Issue 4, 1997, Pages 616-623

  Schmitt, H J ^a   Beutel, K ^a   Schuind, A ^a   Knuf, M ^a   Wagner, S ^a   Muschenborn, S ^a   Bogaerts, H ^a   Bock, H L ^a   Clemens, R ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ANTIBODY TITER; ARTICLE; CELL KILLING; CHILD; DIPHTHERIA; DRUG SAFETY; DRUG TOLERANCE; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PRIORITY JOURNAL; SEROLOGY; TETANUS; VACCINATION; VACCINE PRODUCTION;

EID: 0030831159     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(97)70247-6     Document Type: Article

References (27)

1. A. Galazka Control of pertussis in the world World Health Stat Q 45 1992 4245 4252
2. RM Barkin ME. Pichichero Diphtheria-pertussis-tetanus vaccine: reactogenicity of commercial products Pediatrics 63 1979 256 260
3. A Robinson SGP. Funnell Potency testing of acellular pertussis vaccines Vaccine 10 1992 139 141
4. M Kulenkampff JS Schwartzman J. Wilson Neurological complications of pertussis inoculation Arch Dis Child 49 1974 46 49
5. DL Miller EM Ross R Alderslade MH Bellman NSB. Rawson Pertussis immunization and serious acute neurological illness in children BMJ 282 1981 1595 1599
6. HH Bernstein PE Rothstein Pennridge Pediatric Associates KS Reisinger MM Blatter AM Arbeter Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20- month-old infants Pediatrics 93 1994 656 659
7. JA Englund MD Decker KM Edwards ME Pichichero MC Steinhoff EL. Anderson Acellular and whole-cell pertussis vaccines as a booster dose: a multicenter study Pediatrics 93 1994 37 63
8. M Glode L Joffee K Reisinger M Blatter S Plotkin B Watson Safety and immunogenicity of acellular pertussis vaccine combined with diphtheria and tetanus toxoids in 17- to 24-month-old children Pediatr Infect Dis J 11 1992 530 535
9. G Kanra M Ceyhan D Vandevoorde H. Bogaerts Acellular pertussis diphtheria-tetanus-pertussis vaccine containing separately purified pertussis toxoid, filamentous haemagglutinin and 69 kDa outer membrane protein as a booster in children Eur J Pediatr 152 1993 478 483
10. H-J Schmitt A Schuind M Knuf K Beutel H Schulte-Wissermann M Gahr Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22505 infants J Pediatr 129 1996 695 701
11. D a Greco S Salmaso P Mastrantonio M Giuliano AE Tozzi A Anemona A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis N Engl J Med 334 1996 341 348
12. H-J Schmitt CH Wirsing von König A Neiss H Bogaerts HL Bock H Schulte-Wissermann Efficacy of acellular pertussis vaccine in early childhood after household exposure JAMA 275 1996 37 41
13. O Ruuskanen A Noel A Putto-Laurila J Pêtre C Capiau A Delem Development of an acellular pertussis vaccine and its administration as a booster in healthy adults Vaccine 9 1991 117 121
14. ME Melville-Smith VA Seagroatt JT. Watkins A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralisation test in mice as a method for the estimation of tetanus antitoxin in human sera J Biol Stand 11 1983 137 144
15. ME Melville-Smith A Balfour Estimation of Corynebacterium diphtheria antitoxin in human sera: a comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation test J Med Microbiol 25 1988 279 283
16. U Heininger JD Cherry S Schmitt-Grohe M Uberall S Laussucq T Eckhardt Comparative study of reactogenicity of Lederle/Takeda acellular pertussis component (APDT) and Lederle whole-cell (DTP) pertussis component vaccines and DT vaccine in 10,472 German infants and children [abstract] Pediatr Res 35 1994 1074
17. CL Cody LJ Baraff JD Cherry M Marcy CR. Manclark Nature and rate of adverse reactions associated with DTP and DT immunizations in infants and children Pediatrics 68 1981 650 660
18. LJ Baraff JD Cherry SM. Marcy DTP reactions: relationship of manufacturer lot, potency and endotoxins to reaction rates [abstract] Clin Res 33 1986 129A
19. H-J Schmitt S Müschenborn S Wagner M Knuf HL Bock H Bogaerts Immunogenicity and reactogenicity of a bicomponent and a tricomponent acellular pertussis-diphtheria-tetanus (DTaP) vaccine in primary immunization and as second year booster: a double-blind, randomized trial Int J Infect Dis 1 1996 6 13
20. M Blennow M Granström Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants Pediatrics 84 1989 62 67
21. KM Edwards MD Decker BB Roberta JCH Taylor CC. Hager Booster response to acellular pertussis vaccine in children primed with acellular or whole cell vaccines Pediatr Infect Dis J 10 1991 315 318
22. ME Pichichero AB Francis SM Marsocci JL Green FA Disney C. Meschievitz Safety and immunogenicity of an acellular pertussis vaccine booster in 15- to 20-month-old children previously immunized with acellular or whole-cell pertussis vaccine as infants Pediatrics 91 1993 756 760
23. GR Noble RH Bernier EC Esber C Hardegree AR Hinman D Klein Acellular and whole cell pertussis vaccines in Japan: report of a visit by U.S. scientists JAMA 257 1987 1351 1356
24. C Pim J Farley Adverse reactions to kindergarten DPT boosters—Cranbrook Dis Surveill 9 1988 230 239
25. R Gold D Scheifele L Barreto S Wiltsey G Bjornson W Meekison Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age Pediatr Infect Dis J 13 1994 348 355
26. M Kimura H Kuno-Sakai Y Sato H Kamiya R Nii S Isomura A comparative trial of the reactogenicity and immunogenicity of Takeda acellular pertussis vaccine combined with tetanus and diphtheria toxoids Am J Dis Child 145 1991 734 741
27. H Kamiya R Nii T Matsuda N Yasuda PD Christenson JD. Cherry Immunogenicity and reactogenicity of Takeda acellular pertussis-component diptheria-tetanus-pertussis vaccine in 2- and 3-month-old children in Japan Am J Dis Child 146 1992 1141 1147